Synapse Medicine
What They Do
Digital prescription and medication management platform helping healthcare professionals prescribe safely and manage drug interactions.
Funding
Valuation: Series B+; est. ~€50-100M Series B+. Backed by BPI France, Elaia Partners.
Business Details
- Founded: 2017
- Total Funding: $28M+
- Valuation: ~€50-100M (est.)
- Revenue: N/A (private)
- Employees: ~50-80 (est.)
- Key Milestones: $28M raised (TechCrunch reported). Medication intelligence platform. E-prescription safety.